Vector-Borne Infections
R-Biopharm Australia’s vector-borne infection testing solutions provide comprehensive molecular detection of mosquito-borne viral, bacterial and protozoan pathogens. Using advanced multiplex PCR technology, our panels enable laboratories to identify multiple clinically relevant targets from a single sample, supporting research, surveillance and diagnostic applications across diverse geographic and transmission settings.
Comprehensive Molecular Detection of Vector-Borne Pathogens
Vector-borne infections present unique diagnostic challenges due to the diversity of pathogens involved and the overlap of clinical symptoms between different diseases. R-Biopharm Australia’s multiplex PCR solutions enable laboratories to simultaneously detect a broad range of viral, bacterial and protozoan targets, providing a more comprehensive understanding of complex infection profiles.
Designed to support surveillance, research and specialised diagnostic applications, our vector-borne infection testing panels deliver valuable molecular insights to help laboratories investigate emerging threats, monitor pathogen circulation and make informed decisions in a changing global health landscape.
Vector-Borne Infections Product Portfolio
Vector-Borne Infections
Combinations of viral, bacterial, and protozoan targets with Artemisinin resistance to rapidly inform clinical interventions.
Parasites
- Plasmodium spp.
Resistance Genes
- Artemisenin resistance SNP C580Y in Plasmodium spp.
Viruses
- Dengue Virus 1
- Dengue Virus 2
- Dengue Virus 3
- Dengue Virus 4
- Barmah Forest Virus
- Chikungunya Virus
- Japanese Encephalitis
- Kunjin virus
- Murray Valley Encephalitis Virus
- Ross River Virus
- West Nile virus
- Zika Virus
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 27157S | RIDA®Plex Mosquito-Borne Infections 16 well Step 1 | 12 x 8-well Strips | 96 |
| 27157P | RIDA®Plex Mosquito-Borne Infections 16 well Step 2 | 12 x 384-well Plates | 288 |
| 40331 | RIDA®Plex L RNA Cassette | 10 Cassettes | – |
| 91600 | RIDA®Plex Positive Control Vector-Borne Panels | 10 x 2mL Tubes | – |
Comprehensive Vector-Borne Diagnostic Solutions
Our vector-borne infection testing portfolio supports laboratories with advanced molecular solutions for the detection of mosquito-borne viral, bacterial and protozoan pathogens. Combining multiplex PCR technology with comprehensive target coverage, our solutions provide valuable molecular insights for surveillance, research and specialised diagnostic applications. Backed by trusted global manufacturers and supported by local expertise, R-Biopharm Australia enables laboratories across Australia to investigate vector-borne infections with confidence.
Explore Our Technology
Our vector-borne infection testing solutions are supported by advanced molecular testing platforms designed to deliver reliable performance across complex pathogen detection applications. Through integrated workflows combining nucleic acid extraction, multiplex PCR and automated analysis capabilities, R-Biopharm Australia provides laboratories with flexible solutions for comprehensive vector-borne infection testing. These technologies enable efficient processing of multiple targets while maintaining the accuracy and consistency required for modern molecular diagnostics.
RIDA®Plex IVD panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European IVD Directive 98/79/EC. In the USA: For Research Use Only (RUO). For Research Use Only (RUO), not for use In diagnostic procedures. RIDA®Plex RUO panels are for Research Use Only in any jurisdiction.
